ArticleMolecules (Basel, Switzerland)2025
High-Performance Structures of Biopolymer Gels Activated with Scleroprotein Crosslinkers.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The study explores innovative crosslinking processes for biopolymer gel materials using amino acids and ion-redox initiators to significantly enhance their structural and functional properties. Advanced analytical techniques, including FTIR, Raman spectroscopy, XRD, TEM, TGA, DSC, ToF-SIMS, SEM/EDS, GPC/SEC, and elemental analysis, were employed for comprehensive material characterization. The synthesized materials show potential applications in packaging and medicine, particularly for single-use products with short life cycles. Two crosslinking strategies were developed. The first combines gelatin with polyvinyl alcohol (PVA); keratin hydrolysate; and amino acids such as cysteine, hydroxyproline, proline, and histidine. The second employs endogenous cysteine, activated by ion-redox initiators, leveraging its trans-sulfuration ability to form highly stable polymer networks with optimized mechanical and thermal properties. Notably, the synergy between cysteine and potassium persulfate redox initiators proved particularly effective, making this approach attractive for industrial applications. This study introduces novel crosslinking methods and highlights the potential of amino acid-based strategies for designing advanced biopolymer gels with enhanced properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.